Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects

Summary Background Potassium‐competitive acid blockers (P‐CABs) are emerging as novel treatments for acid‐related disorders including gastroesophageal reflux disease. Tegoprazan and revaprazan are approved P‐CABs in South Korea, but the pharmacodynamics and safety/tolerability of the two drugs have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2020-12, Vol.52 (11-12), p.1640-1647
Hauptverfasser: Sunwoo, Jung, Ji, Sang Chun, Oh, Jaeseong, Ban, Mu Seong, Nam, Ji Yeon, Kim, Bongtae, Song, Geun Seog, Yu, Kyung‐Sang, Jang, In‐Jin, Lee, SeungHwan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!